AdaptHealth Corp. (NASDAQ:AHCO) Shares Sold by Two Sigma Investments LP

Two Sigma Investments LP lessened its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 48.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 154,413 shares of the company's stock after selling 144,345 shares during the quarter. Two Sigma Investments LP owned approximately 0.11% of AdaptHealth worth $1,470,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AHCO. Blue Trust Inc. lifted its position in AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after buying an additional 1,115 shares during the last quarter. Guggenheim Capital LLC increased its stake in shares of AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after buying an additional 1,525 shares during the period. Sterling Capital Management LLC increased its stake in shares of AdaptHealth by 5.2% during the fourth quarter. Sterling Capital Management LLC now owns 33,558 shares of the company's stock worth $319,000 after buying an additional 1,644 shares during the period. Rhumbline Advisers increased its stake in shares of AdaptHealth by 0.5% during the fourth quarter. Rhumbline Advisers now owns 313,110 shares of the company's stock worth $2,981,000 after buying an additional 1,691 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in AdaptHealth by 3.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 57,931 shares of the company's stock valued at $552,000 after purchasing an additional 1,999 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company's stock.

Analysts Set New Price Targets

AHCO has been the topic of several recent analyst reports. Royal Bank of Canada dropped their price target on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research note on Thursday, May 8th. UBS Group decreased their price target on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Robert W. Baird increased their price target on AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Canaccord Genuity Group increased their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Finally, Truist Financial decreased their price target on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $13.40.

AdaptHealth Price Performance

NASDAQ:AHCO traded down $0.12 during trading hours on Friday, hitting $8.90. The company's stock had a trading volume of 693,674 shares, compared to its average volume of 1,284,732. The business's 50-day moving average is $8.79 and its two-hundred day moving average is $9.56. The company has a market capitalization of $1.20 billion, a PE ratio of -5.39, a PEG ratio of 1.08 and a beta of 1.64. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. AdaptHealth Corp. has a 52-week low of $7.11 and a 52-week high of $11.90.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.